Tag: Cancer: Lung
Accuracy, Timing of Pre-Op Lung CA Evaluation Can Be Improved
Most patients have pre-op CT scans; 88 percent have no invasive preoperative staging
Telomere Length May Help Predict Lung Cancer Risk
No significant association seen between telomere length and other types of cancer
![Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer with a specific genetic mutation (epidermal growth factor receptor [EGFR]). A just-approved companion diagnostic test can identify patients who could benefit from this new use.](https://www.ehealth-news.com/wp-content/uploads/2016/01/fdalogo-6-180x84.jpg "FDA Approves Iressa for EGFR+ Metastatic Lung Cancer")
FDA Approves Iressa for EGFR+ Metastatic Lung Cancer
New companion diagnostic kit can identify candidates
Yearly CT May Adequately Monitor Non-Solid Lung Nodules
Surgery found 100 percent curative, regardless of the time to treatment
Lung Disease Under Radar for Many Long-Term Smokers
Many considered disease-free based on their spirometry results
Surgery Deemed Fitting for Some Stage IIIB NSCLC Patients
Longer overall survival in patients undergoing surgical resection, compared to chemo-radiation only
ASCO: PD-1 Immunotherapy Benefits Patients With NSCLC
Fewer side effects, longer survival for nivolumab versus docetaxel
Statins Linked to Improved Survival in Lung Cancer
But more research needed
Two New Lung Cancer Meds Show Promise in Advanced Disease
Two experimental medications target mutation that fuels treatment resistance
Gene Variation May Impact Smoking Cessation Efforts
Researcher suggests a change in screening policies
